AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02872415 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Blood puncture site
Description: Blood puncture site
Study NCT02872415 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood puncture site
Description: Blood puncture site
Study NCT00804427 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish oil (90% triglycerides)
Study NCT00804427 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish oil (60% triglycerides)
Study NCT00804427 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish oil (ethyl esters)
Study NCT00804427 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Soy oil
Study NCT03925792 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Medicine
Description: diet, sleep, exercise and mindfulness
Study NCT03125889 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AquaBeam System
Description: The AquaBeam system delivers a high-velocity saline stream under precise electromechanical control and live ultrasound guidance to ablate prostatic glandular tissue without the production of heat. The physician uses ultrasound imaging to plan the treatment contour and depth to define the treatment region. The AquaBeam ablates the target tissue, adhering to the pre-defined treatment zone.
Study NCT00563797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mecamylamine
Description: mecamylamine 10mg/day for 12 weeks
Study NCT00563797 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill
Study NCT02303795 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin
Description: Patients will take the warfarin once daily (q.d.). The individual doses will be titrated as needed to maintain a target INR of 2.0-3.0.~Patients with 65 > years old, should take warfarin (2,5mg/day) and all others patients should take 5mg/day.
Study NCT02343653 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition and strength training
Description: All participants will receive professional dietary guidance and a protein supplement. At the beginning and end of the intervention every participant will be part of a program consisting of:~Test of muscle strength, blood samples, assessment of nutritional status, MRi scan, test of Quality of life by questionnaire and test of the ammonium metabolism. After one year readmissions will by registered.~The intervention group will receive supervised training.
Study NCT01905813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB040093
Description: Escalating doses starting at 100 mg every day (QD)
Study NCT01905813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB040093 + itacitinib
Description: INCB040093 dose to be determined at completion of Part 1 of the study + itacitinib at a starting dose of 400 mg, QD with escalations planned up to 600 mg QD.
Study NCT02343653 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition
Description: All participants will receive professional dietary guidance and a protein supplement. At the beginning and end of the intervention every participant will be part of a program consisting of:~Test of muscle strength, blood samples, assessment of nutritional status, MRi scan, test of Quality of life by questionnaire and test of the ammonium metabolism. After one year readmissions will by registered.
Study NCT00139451 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pediasure
Description: With the assistance of a research dietician, we will prescribe and monitor the use of a liquid food supplement (Pediasure). Adjustments to the supplementation will be made based on weight measurements in the clinic with subjects wearing paper gowns at 2 and 4w, and monthly thereafter, and repeat dietary intake and TEE assessment at 6 and 12mo.
Study NCT00139451 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GH
Description: Growth Hormone will be 0.3mg/kg/week, given SC once daily.
Study NCT02666768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon gamma-1b
Description: gamma interferon-1b dose escalation over first 4 weeks of study to 100 mcg SC 3 times weekly
Study NCT03524443 — intervention group
Intervention type: BEHAVIORAL
Intervention: Art Therapy treatment
Description: The main objective is to describe the evolution at 3 months on the alexithymic dimension in the course of a treatment in art therapy, in patients with anorexia nervosa or bulimia.~Art therapy is a generic term grouping different artistic disciplines adapted and used for therapeutic purposes. It is through commitment to creative work that the therapeutic work of elaboration and reflection takes place in contrast to verbal psychotherapies and mediated psychotherapies that use speech as the main therapeutic tool. All forms of practice referring to categories of art can be used: painting, music, modeling, dance, theater and writing
Study NCT00882752 — intervention group
Intervention type: PROCEDURE
Intervention: molecular analysis
Description: bowel disease
Study NCT03110237 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Balance Training (BT) class
Description: Circuit training class with 11 stations, including: step-ups, ball kicking, balance beam, sit to stand, walk and carry, tandem walking, walking over a mat, walking up a ramp, walking at different speeds, speed walk, dual task walking.
Study NCT03110237 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fallproof Balance Training (BT) class
Description: There are four categories of exercises in this approach including: center of gravity control training (e.g. multi-directional weight shifts in standing, standing with altered base of support), multisensory training (e.g. standing on compliant surfaces, eyes open/closed), postural strategy training (e.g. resisted perturbation to facilitate ankle, hip or step strategy), and gait pattern variation training (e.g. walking with altered base of support , walking over and around obstacles). Each training category will be allocated 5 minutes with two exercises in each category. An additional 5 minutes will be allotted for games to challenge balance (balloon volleyball, pass the potato, circle soccer).There will be opportunity for group discussion and observational learning.
Study NCT02031861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nifedipine CR tablets (Xin Ran)
Study NCT02031861 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nifedipine CR tablets (Adalat)
Study NCT00535210 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cardiovascular training
Description: The cardiovascular training group will receive their usual therapy plus 3 days of 30 minutes of exercise per week. This program will last for 6 weeks while the participant is in the hospital. The cardiovascular training program will include pushing and pulling on pulleys, wheeling over mats, punching a boxing bag, and using an arm ergometer. The balance training group will receive their usual therapy plus 3 days of 30 minutes of sitting balance activities. This program will last for 6 weeks while the participant is in the hospital.
Study NCT00535210 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Balance training
Description: The balance training group will receive their usual therapy plus 3 days of 30 minutes of sitting balance activities. This program will last for 6 weeks while the participant is in the hospital. The balance training program will include sitting on mats - moving arm support from in front of the body to behind body, moving from sitting to lying and back up, and catching soft foam ball thrown directly to centre of chest and throwing it back.
Study NCT03695900 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Targeting SpO2 at 93-95%
Description: FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours
Study NCT03695900 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Targeting SpO2 at 90-92%
Description: FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours.
Study NCT04127279 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cream
Description: The enriched cream is self-administered and contains a blend of 4 essential oils, namely Juniperus phoenicea gum extract, Copaifera officinalis resin, Aniba rosaeodora wood oil and Juniperus virginiana oil.~The placebo cream is devoid of the essential oils
Study NCT04127279 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cream
Description: The enriched cream is self-administered and contains a blend of 4 essential oils, namely Juniperus phoenicea gum extract, Copaifera officinalis resin, Aniba rosaeodora wood oil and Juniperus virginiana oil.~The placebo cream is devoid of the essential oils
Study NCT01518322 — intervention group
Intervention type: DEVICE
Intervention: NIOX MINO®
Description: Fractional Exhaled Nitric Oxide (FeNO) will be measured with the NIOX MINO®
Study NCT04062669 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Low dose formulation of RG SAM (CNE) vaccine (GSK3903133A)
Description: Subjects in the low dose (Ld-) RG SAM (CNE) group will receive 2 doses of RG SAM (CNE) low dose formulation, administered intramuscularlyat Days 1 and 61.
Study NCT04062669 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Medium dose formulation of RG SAM (CNE) vaccine (GSK3903133A)
Description: Subjects in the medium dose (Md-) RG SAM (CNE) group will receive 1 doses of RG SAM (CNE) medium dose formulation, administered intramuscularly at Day 1.
Study NCT04062669 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lower dose formulation of RG SAM (CNE) vaccine (GSK3903133A)
Description: Subjects in the Lower dose (Lrd-) RG SAM (CNE) group will receive 2 doses of RG SAM (CNE) lower dose formulation, administered intramuscularly, according to a 0, 2-month schedule (i.e. at Days 1 and 61)
Study NCT04062669 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lowest dose formulation of RG SAM (CNE) vaccine (GSK3903133A)
Description: Subjects in the Lowest dose (Ltd-) RG SAM (CNE) group will receive 2 doses of RG SAM (CNE) lowest dose formulation, administered intramuscularly, according to a 0, 2-month schedule (i.e. at Days 1 and 61)
Study NCT04062669 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Placebo
Description: Subjects in the Saline Placebo group will receive 2 doses of saline Placebo, administered intramuscularly Day 1 and 61.
Study NCT04062669 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: RabAvert
Description: Subjects in the RabAvert Group will receive 2 doses of RabAvert vaccine, administered intramuscularly, at Days 1 and 61.
Study NCT03521388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Take care of your mood (CUIDA TU ANIMO in Spanish)
Description: The adolescents will be registered in the Website www.cuidatuanimo.org
Study NCT03521388 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: The adolescents will visit the Website www.cuidatuanimo.org, but they can not register
Study NCT03901677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tai-chi training
Description: Group exercise apply with physiotherapist
Study NCT03694080 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Calcium electroporation
Description: Patients with potentially curable colorectal rectal cancer will be treated preoperatively
Study NCT02338648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUN-131 1.5% TDS
Description: Active transdermal patch
Study NCT02338648 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo TDS
Description: Placebo transdermal patch for blinding
Study NCT04304989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mHealth program
Description: mobile health applications
Study NCT04304989 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: usual care
Description: usual care
Study NCT03710408 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous hydration
Description: Participants assigned to the intravenous hydration arm will receive their hydration therapy through an intravenous access. This access will be achieved by inserting a BD VenflonTM Pro Safety - 22G in a vein in the dorsal side of the hand or further up the forearm. If the participants is suspected of becoming delirious and at risk of removing the cannula from the hand/forearm, it may be inserted at the dorsal side of the foot. The clinical staff judge this risk and decide site of placement.~Furthermore, a sham subcutaneous access device BD Saf-T-Intima™ Integrated Safety Catheter System will be placed on the abdomen without piercing the skin.
Study NCT03710408 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subcutaneous hydration
Description: Participants assigned to the subcutaneous hydration arm will receive their hydration therapy through a subcutaneous access. This access will be achieved by placing a BD Saf-T-Intima™ Integrated Safety Catheter System on the abdomen or, alternatively if the participants is suspected of becoming delirious and at risk of removing the needle, it will be placed on the back at the scapular region.~Furthermore, a sham IV access device BD VenflonTM Pro Safety - 22G will be placed on the dorsal side of the hand without piercing the skin.
Study NCT02246751 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Targeted Training for trunk control
Description: Orthotics Research and Locomotor Research Unit (ORLAU) standers will be custom fit to help the child train at the segmental level of the trunk where they begin to lose control of posture. The typical course of treatment involves loaning the customized equipment to each family for use in their home or in their child's educational setting. Training occurs once daily usually for 30-45 minutes. This is done 5 or 6 days per week. Training programs typically involve playing with balls or balloons or video games that motivate the child to hold the head erect and to wave the arms and hands and move the upper body. The researchers evaluate children every 8 weeks and adjust the stander to lower levels of support as the child gains control.
Study NCT02301169 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Heat pain stimuli A
Study NCT02301169 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Video A
Study NCT02301169 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Administration of T4P1001 capsules
Description: This treatment is given as add on therapy to patients' regular analgesic
Study NCT02301169 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Heat pain stimuli B
Study NCT02301169 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Video B
Study NCT02301169 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Administration of placebo capsules
Description: This treatment is given as add on therapy to patients' regular analgesic
Study NCT04573322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trans Sodium Crocetinate
Description: TSC, at the optimum safe and tolerable dose determined in the lead-in phase, administered via IV bolus every 6 hours for up to 15 days
Study NCT04573322 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal Saline, in an equivalent volume by participant body weight, administered via IV bolus every 6 hours for up to 15 days
Study NCT01996930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Haelan tape (steroid impregnated tape)
Description: Medicated plaster applied daily. Max daily dose = 0.1mg (25cm squared per day)Maximum duration of treatment = 28 days
Study NCT01996930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Silver Nitrate
Description: Cautery with silver nitrate cutaneous stick undertaken twice weekly for a maximum duration of treatment = 28 days
Study NCT00659711 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Januvia (Sitagliptin) 100 mg
Description: The first group will be started on 100 mg sitagliptin daily for 12 weeks
Study NCT00659711 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: will be placed on a placebo for 12 weeks.
Study NCT03126773 — intervention group
Intervention type: DRUG
Intervention: BAY86-4891
Description: Drospirenone 0.25 mg + estradiol hemihydrate 0.5 mg (Angeliq Micro, G03FA17).Dosage form is one tablet a day.
Study NCT03295838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment
Description: See Arm description
Study NCT00075816 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Allogeneic bone marrow transplantation
Description: Bone marrow transplant from HLA compatible unrelated donors.
Study NCT00075816 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral blood stem cell transplantation
Description: Peripheral blood transplant from HLA compatible unrelated donors.
Study NCT04421599 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Necessity of Aspiration
Description: The patients who met the inclusion criteria and agreed to participate in the study were assigned to the Experimental Group A who were administered IM injection during which aspiration lasted for 5-10 seconds, to the Control Group who were administered IM injection during which aspiration lasted for 1-2 seconds, and to the Experimental Group B who were not administered IM injection according to the stratified block randomization list. The same Intramuscular Injection Application Protocol was applied while all the injections were administered.
Study NCT02483676 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treadmill plus anklebot
Description: This intervention employs the use of the adaptive anklebot control system to complement treadmill exercise training over a 6-week intervention period.
Study NCT02483676 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill only
Description: This intervention employs the use of a treadmill for gait exercise training over a 6-week intervention period
Study NCT00183547 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Living in Harmony depression prevention program
Description: Weekly therapy sessions consisting of cognitive behavioral therapy (CBT), culturally-relevant education, and support
Study NCT00183547 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Depression-prevention education and support
Description: Weekly therapy sessions offering general depression-prevention education and support
Study NCT03142477 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. No true or placebo therapeutic touch intervention will be performed.
Study NCT03142477 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaires
Description: Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. No true or placebo therapeutic touch intervention will be performed.
Study NCT03142477 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. No true or placebo therapeutic touch intervention will be performed.
Study NCT04413357 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balanced Nutritional Drink
Description: Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat intended for use as Supplemental Nutrition.
Study NCT04413357 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Specific, Balanced Nutritional Drink (DMA)
Description: Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat, designed for people living with diabetes and intended for use as Supplemental Nutrition available in retail setting.
Study NCT04413357 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Specific, Balanced Nutritional Drink DMB
Description: Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat, designed for people living with diabetes and intended for use as Supplemental Nutrition.
Study NCT02568410 — intervention group
Intervention type: PROCEDURE
Intervention: coronary artery bypass grafting using cardiopulmonary bypass
Description: no study intervention. Study cohort will undergo coronary artery bypass grafting using cardiopulmonary bypass according to standard practices at DUMC
Study NCT03916055 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure and response prevention (ERP)
Description: The intervention consists of 10 modules/chapters for children/adolescents, delivered over 10. Each of the 10 modules includes age-appropriate texts, animations and exercises. The intervention is primarily based on ERP techniques. During the treatment, participants are instructed to practice suppressing their tics, this is known as 'response prevention'. Then, with the help of their caregiver/parent, the participant is instructed to provoke premonitory urges (a sensation usually felt before a tic is expressed), while still suppressing tics, which is known as 'exposure'.~The parent is provided with her/his own separate login to the internet platform, which consists of 10 separate modules/chapters. The parent intervention consists mainly of information regarding parent coping strategies, social support and functional analysis relating to tics. Both the child/adolescent and the parent have individual access to the same therapist.